In a recent update, Maxim Group has maintained its "Buy" rating for Nutex Health (NUTX, Financial). The decision was announced on May 20, 2025, reflecting continued confidence in the company's stock performance.
Analyst Anthony Vendetti from Maxim Group has raised the price target for Nutex Health (NUTX, Financial) to $225.00 from the previous target of $100.00. This adjustment signifies a significant 125% increase in the projected price target, underlining positive expectations for the company's future stock valuation.
The adjustment comes as part of Maxim Group's analysis, aligning with a persistent "Buy" rating for Nutex Health (NUTX, Financial). The currency for the adjusted price target is USD. Investors and market watchers should note this development as it reflects a strong recommendation for Nutex Health's stock, suggesting potential growth and profitability.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 3 analysts, the average target price for Nutex Health Inc (NUTX, Financial) is $193.67 with a high estimate of $300.00 and a low estimate of $56.00. The average target implies an upside of 9.43% from the current price of $176.98. More detailed estimate data can be found on the Nutex Health Inc (NUTX) Forecast page.
Based on the consensus recommendation from 3 brokerage firms, Nutex Health Inc's (NUTX, Financial) average brokerage recommendation is currently 2.0, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Nutex Health Inc (NUTX, Financial) in one year is $87.47, suggesting a downside of 50.57% from the current price of $176.975. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Nutex Health Inc (NUTX) Summary page.
